Cevostamab - CAS 2249888-53-5

Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized bispecific antibody targeting FcRH5/CD3. It binds to FcRH5 expressed on multiple myeloma (MM) cells and CD3 on T cells, promoting T cell synapse formation and inhibiting B-cell malignancies.

Immunology/Inflammation related, Integrin

Cytoskeletal Signaling, Immunology/Inflammation

2249830

-20°C

Ice Packs

Inhibitory Antibodies